-
Featured Authors
-
Archives
- May 2013
- April 2013
- March 2013
- February 2013
- January 2013
- December 2012
- November 2012
- October 2012
- September 2012
- August 2012
- July 2012
- June 2012
- May 2012
- April 2012
- March 2012
- February 2012
- January 2012
- December 2011
- November 2011
- October 2011
- September 2011
- August 2011
- July 2011
- June 2011
- May 2011
- April 2011
- March 2011
- February 2011
- January 2011
- December 2010
- November 2010
- October 2010
- September 2010
- August 2010
- July 2010
- June 2010
- May 2010
- April 2010
- March 2010
- February 2010
- January 2010
- December 2009
- November 2009
- October 2009
- September 2009
- August 2009
- July 2009
- June 2009
- May 2009
- April 2009
- March 2009
- February 2009
- January 2009
- December 2008
- November 2008
- October 2008
- September 2008
- August 2008
- July 2008
- June 2008
- May 2008
- April 2008
- March 2008
- February 2008
-
Meta
Tag Archives: NIH
Tech Transfer Summit North America
The National Institutes of Health, BIO, and others are sponsoring the Tech Transfer Summit North America at NIH on 3-4 October 2011. Programming includes Translational Medicine & Funding Innovation, Successful Implementation of Biotech Innovation Strategies Worldwide, and Building Better Academia-Industry Collaborations: How will Big Pharma fill its early-stage Pipeline in 5 years’ time, among other topics. BIO’s President and CEO James C. Greenwood will give one keynote speach on the ”Barriers to Innovation in biotechnology, and Read More >
A Center for Advancing Translational Science can spur new therapies
Sometimes, spurring the development of new drugs and therapies can be like trying to a cross shark-infested water without a bridge, Dr. Francis Collins, director of NIH, said during his keynote at the Translational Research Forum during the 2011 BIO International Convention. However, during a time of unprecedented scientific advances, but increasingly limited resources, the public and private sectors must learn to combine their respective efforts to relieve human suffering. Dr. Collins gave a rapid Read More >
Health
Leave a comment
Email This Post
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
Tags: 2011 BIO International Convention, American Clean Energy and Security Act, BIO International Convention, Cures Acceleration Network, FDA, Food and Drug Administration, National Center for Advancing Translational Science, National Institute of Health, NIH, Phase Zero, translational research
Translational Research Forum at BIO International Convention
BIO is hosting a Translation Research Forum at the BIO International Convention. NIH Director Collins keynotes an event that will explore how private, public and academic sectors can leverage meaningful partnerships, highlight emerging best practices, explore risk-sharing at the clinical research stage, and explore ways to bridge the gap in funding and know-how necessary to take university research to the next level. Read the Press Release for more information about panels and speakers. For registration, conference Read More >
Fabry Patient Law Suit and Request to NIH for March-in Petition Rehearing
An article out of the Genomics Law Report discussing the recent law suit citing violations of the Bayh Dole Act. A second article from Patent Docs discusses the request for rehearing of the patients petition to the NIH for march-in.
AUTM’s 2010 Better World Report Highlights
AUTM released their Better World Report for 2010 highlighting academic innovations commercially developed through technology transfer that are improving the quality of life. Here is a quote from their press release. A device that allows the blind to ―see‖ via electrical pulses applied to the tongue…a collagen scaffold to treat damaged joints…a new vaccine to prevent shingles…an artificial lung that provides patients with both mobility and comfort during treatment…a program that vastly improves literacy among Read More >
Patently BIOtech
Leave a comment
Email This Post
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
Tags: Association of Technology Transfer Managers, AUTM, Bayh-Dole, BIO, biotechnology, economic development, federally funded research, Global Health, government funded research, healthcare, Licensing technology, modern medicine, new drug development, NIH, patents, Research and Development, Senator Birch Bayh, Senator Dole
